| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JCONREL.2010.03.027 |
| P698 | PubMed publication ID | 20381556 |
| P50 | author | Malou Henriksen-Lacey | Q37840518 |
| Dennis Christensen | Q37840535 | ||
| Peter Andersen | Q54029065 | ||
| Thomas Lindenstrøm | Q56884096 | ||
| Yvonne Perrie | Q91734501 | ||
| Else Marie Agger | Q111279894 | ||
| P2093 | author name string | Vincent W. Bramwell | |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine | Q134808 |
| P304 | page(s) | 102-108 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Journal of Controlled Release | Q6295046 |
| P1476 | title | Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response | |
| P478 | volume | 145 |
| Q38098855 | A case-study investigating the physicochemical characteristics that dictate the function of a liposomal adjuvant |
| Q34271517 | A novel and efficient nicotine vaccine using nano-lipoplex as a delivery vehicle |
| Q34685874 | A polymer/oil based nanovaccine as a single-dose immunization approach |
| Q37410524 | Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis |
| Q91731105 | Advancements in Prophylactic and Therapeutic Nanovaccines |
| Q40553161 | Allergen-loaded strontium-doped hydroxyapatite spheres improve allergen-specific immunotherapy in mice |
| Q38126953 | An overview of adjuvant formulations and delivery systems. |
| Q35100779 | An overview on the field of micro- and nanotechnologies for synthetic Peptide-based vaccines |
| Q47351571 | Application of Pharmacokinetics Modelling to Predict Human Exposure of a Cationic Liposomal Subunit Antigen Vaccine System. |
| Q38123937 | Applications of nanotechnology for immunology |
| Q36618500 | Beyond antigens and adjuvants: formulating future vaccines |
| Q27014949 | CD4(+) T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines |
| Q41678461 | Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani |
| Q38028994 | Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status |
| Q37867105 | Cationic liposomes as vaccine adjuvants |
| Q95482822 | Cell recruitment and antigen trafficking in afferent lymph after injection of antigen and poly(I:C) containing liposomes, in aqueous or oil-based formulations |
| Q37641676 | Cryogenic transmission electron microscopy of recombinant tuberculosis vaccine antigen with anionic liposomes reveals formation of flattened liposomes |
| Q35812875 | Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens |
| Q99584073 | Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against Mycobacterium tuberculosis Infection |
| Q92084132 | Efficient induction of cell-mediated immunity to varicella-zoster virus glycoprotein E co-lyophilized with a cationic liposome-based adjuvant in mice |
| Q34947144 | Endocine™, N3OA and N3OASq; three mucosal adjuvants that enhance the immune response to nasal influenza vaccination |
| Q35593603 | Formulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants |
| Q35488154 | Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A. |
| Q92051245 | High Molecular Weight Chitosan-Complexed RNA Nanoadjuvant for Effective Cancer Immunotherapy |
| Q42228751 | Highly versatile immunostimulating nanocapsules for specific immune potentiation. |
| Q37793242 | Immunotherapy in asthma |
| Q64240862 | Increasing Cellular Immune Response in Liposomal Formulations of DOTAP Encapsulated by Fusion Protein Hspx, PPE44, And Esxv, as a Potential Tuberculosis Vaccine Candidate |
| Q61803783 | Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines |
| Q37067294 | Induction of Unconventional T Cells by a Mutant Mycobacterium bovis BCG Strain Formulated in Cationic Liposomes Correlates with Protection against Mycobacterium tuberculosis Infections of Immunocompromised Mice |
| Q38169040 | Key roles of adjuvants in modern vaccines |
| Q38729260 | Liposomal adjuvants for human vaccines |
| Q99579442 | Liposomal gp100 vaccine combined with CpG ODN sensitizes established B16F10 melanoma tumors to anti PD-1 therapy |
| Q37854063 | Liposomal vaccine delivery systems |
| Q26765446 | Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators |
| Q38068245 | Liposome-based delivery system for vaccine candidates: constructing an effective formulation. |
| Q54690087 | Manufacturing Methods for Liposome Adjuvants. |
| Q77791988 | Metal nanomaterials: immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease |
| Q92914662 | Microfluidic-prepared DOTAP nanoparticles induce strong T-cell responses in mice |
| Q42724009 | Modern Vaccines/Adjuvants Formulation Session 6: Vaccine &Adjuvant Formulation & Production 15-17 May 2013, Lausanne, Switzerland |
| Q35949214 | Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine |
| Q91667785 | Nanomaterial-Based Vaccine Adjuvants |
| Q36909492 | Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates |
| Q42235032 | Novel vaccine delivery system induces robust humoral and cellular immune responses based on multiple mechanisms |
| Q30421028 | Protein antigen adsorption to the DDA/TDB liposomal adjuvant: effect on protein structure, stability, and liposome physicochemical characteristics |
| Q38753321 | Radiolabelling of Antigen and Liposomes for Vaccine Biodistribution Studies |
| Q49023254 | Switching the Immunogenicity of Peptide Assemblies Using Surface Properties |
| Q37834166 | Systematic Investigation of the Role of Surfactant Composition and Choice of oil: Design of a Nanoemulsion-Based Adjuvant Inducing Concomitant Humoral and CD4+ T-Cell Responses. |
| Q45831503 | Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants |
| Q49829267 | The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases |
| Q26777053 | The Use of Synthetic Carriers in Malaria Vaccine Design |
| Q38369004 | The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin. |
| Q37398283 | Trehalose diester glycolipids are superior to the monoesters in binding to Mincle, activation of macrophages in vitro and adjuvant activity in vivo |
| Q37668409 | Working together: interactions between vaccine antigens and adjuvants |
Search more.